elect rolyte.ppt

MosaHasen 35 views 48 slides Jul 12, 2024
Slide 1
Slide 1 of 48
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48

About This Presentation

f


Slide Content

Electrolytes
Disturbances
DR/ Shafiq .A. Al-imad

Hypokalemia

Definition
Total body K : 3500 mmole(98%
intracellular, 2% extracellular)
Normal serum potassium 3.5-5.5 mEq/L
Hypokalemia is a serum potassium less
than 3.5 mEq/L

American diet : 100 mmole
Haemostasis system of K :
1) kidney , intestine
2) Shifting of K between the ECF and
ICF

Blood pressure
ReninRenin
Aldo
K
+
excretion rate and acid-base status ?
HHyyppookkaalleemmiiaa&&PPaarraallyyssiiss
LLoowwKK
++
eexxccrreettiioonnaanndd
nnoorrmmaallaacciidd--bbaassee
lSPP
lBarium poisoning
lFPP lHypernatremic HPP
None Family history Hypernatremia
High K
+
excretion and
abnormal acid-base
Acid-base state ?
Clue
Hyperthyroidism ?
lTPP
YES NO Metabolic Acidosis
NH
+
4excretion
(UAG, UOG)
LowHigh
Toluene
Profound diarrhea
RTA
Metabolic Alkalosis
Renin
Normal
GS or BS
Diuretics
Vomiting
High
Primary
mineralocorticoid excess
AldoAldo
Primary
Aldosteronism
Licorice use
AME
Ectopic ACTH
Liddlesyndrome
Lin SH et al. Am J Emerg Med 2003 (

Case 1
A 43 yo male patient with HTN has been on
atenolol and HCTZ was found to have a serum
K+ 3.2 meq/L.
Case 2
A 55 yo diabetic female was admitted to the
ICU with severe vomiting, diarrhea and muscle
weakness, initial work up revealed serum K+
2.1 meq/L.

Symptoms
Mild to moderate hypokalemia
3 and 3.5 meq/L; this degree of
potassium depletion usually produces
no symptoms, except for
patients with heart disease ( taking digitalis
or undergoing cardiac surgery or
advanced cirrhosis.

Treatment of mild to moderate
hypokalemia
. In general, the loss of 200 to 400 meq
of potassium is required to lower the
plasma potassium concentration from
4.0 to 3.0 meq/L
Repletion as oral potassium chloride in
divided doses over few days
Treat the underlying cause

Treatment of mild to moderate
hypokalemia
For patients who can’t tolerate oral KCL
I.V KCL where 20 to 40 meq of
potassium is added to each liter of fluid.
A saline rather than a dextrose solution
is preferred for initial therapy, since the
administration of dextrose can lead to a
transient 0.2 to 1.4 meq/L reduction in
the plasma potassium concentration

SEVERE HYPOKALEMIA
Symptoms
Muscle weakness and paralysis
Renal dysfunction
ECG changes and arrhythmias

ECG changes
depression of the ST segment,
decrease in the amplitude of the T wave,
and
increase in the amplitude of U waves
which occur at the end of the T wave. U
waves are often seen in the lateral
precordial leads V4-V6.

Treatment of severe
hypokalemia
. A patient with a plasma potassium
concentration of 2 meq/L, for example, may
have a 400 to 800 meq potassium deficit
The maximum rate of intravenous potassium
administration is 10(peripheral line) to
20(central line) meq/h, although higher rates
have been given to selected patients with
paralysis or life-threatening arrhythmias

Treatment of severe
hypokalemia
In this setting, solutions containing as
much as 200 meq of potassium per liter
(20 meq in 100 mL of isotonic saline)
have been used. These solutions
should be infused into a large vein (
femoral vein, subclavian vein, or internal
jugular vein)

Treatment of severe
hypokalemia
Accidental administration of very large
quantities of intravenous potassium can
be avoided by limiting the amount of
potassium per container (eg, 20 meq in
100 mL of isotonic saline)

Treatment of severe
hypokalemia
Careful monitoring of the physiologic
effects of severe hypokalemia (ECG
abnormalities, muscle weakness or
paralysis) is essential .
Once these problems are no longer
severe, the rate of potassium repletion
should be slowed (to 10 meq/h) even
though there is persistent hypokalemia.

If patient had refractory hypokalemia in
spite of adequate replacement so could
be :
1/ persistent cause like vomiting or
diuretics
2/ hypomagnesaemia
3/ dextrose containing solutions

Hyperkalemia

Definition
Normal serum potassium 3.5-5.5 mEq/L
Hyperkalemia is a serum potassium
greater than 5.5 mEq/L

Case 1
A 63 yo male patient with DM, HTN, CHF
has been on digoxin, captopril and
aspirin. Routine work up showed creat.
2.5 mg/dL and K+ 6.5 meq/L.
Q)What are the possible causes of the
hyperkalemia.
Q)How to treat.

symptoms
severe symptoms of hyperkalemia
usually do not occur until the plasma
potassium concentration is above 7.0
meq/L (unless the rise has been very
rapid).
severe muscle weakness, or
marked electrocardiographic changes

ECG changes
Tall peaked and symmetrical T
wave.(early)
Progressive slowing of impulse
conduction causing the PR interval to
lengthen and the QRS duration to
increase.
The P wave may disappear as a result
of atrial standstill or arrest.

ECG changes
Ultimately the QRS widens further due
to a severe conduction delay and may
become "sine wave," resulting in
ventricular standstill and a flat line

EKG Changes
Peaked T Waves

EKG Changes
Widening of QRS Complex

EKG Changes
Ventricular Tach/Torsades

Treatment of hyperkalemia
Is the value accurate??
Are there EKG changes??
Is there evidence of Hemolysis on lab
specimen??
Recheck blood

Treatment
1-Stabilize myocardial membrane
2-Drive extracellular potassium into the
cells
3-Removal of Potassium from the body

Case 2
A 35 yo male patient with CRF presented
to the ER with rapid shallow breathing
hypotension and bradycardia found to
have K+ 8.5 meq/L
Q)Which of the following does not affect
K level
Q)which does actually remove K from the
body
1) Ca gluconate 2) NaHCO3
3) Glucose / insulin4) B-agonists
5)CER (kayexalate) 6) Dialysis

Treatment of hyperkalemia
Asymptomatic patient with serum K+ of
6.5 meq/L & no ECG changes can be
treated only with a cation exchange
resin (Kayexalate®),
Patients with a value below 6 meq/L can
often be treated with
a low potassium diet and
diuretics.

Treatment of severe
hyperkalemia
Calcium
Calcium directly antagonizes the
membrane actions of hyperkalemia.
The protective effect of calcium begins
within minutes, but is relatively short-
lived

Treatment of severe
hyperkalemia
The usual dose is 10 mL (1 ampul) of a 10
percent calcium gluconatesolution infused
slowly over 2 to 3 minutes with constant
cardiac monitoring.
This dose can be repeated after 5 minutes if
the ECG changes persist.(no maximum dose)
Calcium should not be given in bicarbonate-
containing solutions (leads to calcium
carbonateprecipitation).

Treatment of severe
hyperkalemia
Insulin and glucose
Lowers the plasma K+concentration by
driving potassium into the cells, by
enhancing the activity of the Na-K-
ATPase pump in skeletal muscle
10 U plus 50 mL of a 50 percent
glucose solution as a bolusfollowed by
a glucose infusion to prevent
hypoglycemia

Treatment of severe
hyperkalemia
Effective therapy usually leads to a 0.5
to 1.5 meq/L fall in the plasma
potassium concentration, an effect that
begins in 15 minutes, peaksat 60
minutes, and lasts for several hours

Treatment of severe
hyperkalemia
Sodium bicarbonate
Raising the systemic pH with sodium
bicarbonate results in hydrogen ion
release from the cells (as part of the
buffering reaction).
This change is accompanied by
potassium movement into the cells to
maintain electroneutrality

Treatment of severe
hyperkalemia
The potassium-lowering action of
sodium bicarbonate is most prominent
in patients with metabolic acidosis.
It begins within 30 to 60 minutes and
persists for several hours
is 45 meq (1 ampul of a 7.5 percent
sodium bicarbonate solution) infused
slowly over 5 minutes, repeat in 30
minutes if necessary

Treatment of severe
hyperkalemia
Beta2-adrenergic agonists
Drive potassium into the cells by
increasing Na-K-ATPase activity.
Albuterol (10 to 20 mg in 4 mL of saline
by nasal inhalation over 10 minutes

Treatment of severe
hyperkalemia
Cation exchange resin
sodium polystyrene sulfonate (Kayexalate®).
Takes up potassium and releases sodium.
Each gram of resin may bind1 meq of K+
and release 1 to 2 meq of sodium.
The oral dose is usually 20 grams given with
100 mL of a 20 percent sorbitol solution to
prevent constipation, repeat every 4 to 6
hours as necessary.

Treatment of severe
hyperkalemia
When given as an enema, 50 grams of resin
is mixed with 50 mL of 70 percent sorbitol
plus 100 to 150 mL of tap water.
This solution should be kept in the colon for
at least 30 to 60 minutes and preferably two
to four hours.
Each enema can lower the plasma potassium
concentration by as much as 0.5 to 1 meq/L
and can be repeated every two to four hours.

Treatment of refractory
hyperkalemia
Hemodialysiscan be used if
The conservative measures listed
above are ineffective
Refractory hyperkalemia usually such
patient had very low GFR.
The patient has marked tissue
breakdown and is releasing large
amounts of potassium from the injured
cells

Case 2
A 35 yo male patient with CRF presented
to the ER with rapid shallow breathing
hypotension and bradycardia found to
have K+ 8.5 meq/L
Q)Which of the following does not affect
K level
Q)which does actually remove K from the
body
1) Ca gluconate 2) NaHCO3
3) Glucose / insulin4) B-agonists
5)CER (kayexalate) 6) Dialysis

Thanks, any question
Tags